Codes / ICD10CM / E71.2

E71.2 Disorder of branched-chain amino-acid metabolism, unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Disorder of Branched-Chain Amino-Acid Metabolism, Unspecified (ICD-10-CM Code: E71.2)

Name of the Condition

  • Disorder of branched-chain amino-acid metabolism, unspecified.

Summary

This condition involves abnormalities in the body's ability to process branched-chain amino acids (BCAAs), such as leucine, isoleucine, and valine. Disruptions in their metabolism can lead to the accumulation of toxic byproducts, potentially causing neurological or systemic complications if untreated. The term "unspecified" indicates the condition is diagnosed without further subclassification.

Causes

Genetic mutations affecting enzymes or transporters involved in the breakdown or utilization of branched-chain amino acids. These disorders are typically inherited in an autosomal recessive pattern, though specific inheritance patterns may vary.

Risk Factors

  • Family history of metabolic disorders.
  • Consanguinity (parents who are closely related).
  • Certain ethnic or geographic populations with higher carrier rates for specific mutations.

Symptoms

  • Developmental delay or regression.
  • Lethargy or poor feeding in infants.
  • Vomiting or poor weight gain.
  • Neurological symptoms, such as seizures or abnormal muscle tone.
  • Metabolic crises, including ketoacidosis or hyperammonemia, in severe cases.

Diagnosis

Diagnosis involves biochemical testing to measure amino acid levels in blood or urine, often supplemented by genetic testing to identify specific mutations. Newborn screening may detect elevated levels of branched-chain amino acids or their byproducts.

Treatment Options

Treatment focuses on managing metabolic crises and preventing complications. This may include dietary modifications to limit BCAA intake, supplementation with essential nutrients, and medications to address specific symptoms. In severe cases, hospitalization for metabolic stabilization may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of the disorder and timely intervention. Early diagnosis and adherence to treatment can improve outcomes, but neurological damage may occur if left untreated. Regular follow-up with metabolic specialists is essential to monitor growth, development, and metabolic stability.

Complications

  • Neurological damage, including intellectual disability or seizures.
  • Metabolic crises, such as ketoacidosis or hyperammonemia.
  • Growth failure or developmental delays.
  • Organ damage from chronic metabolic stress.

Lifestyle & Prevention

  • Adherence to prescribed dietary restrictions and supplements.
  • Avoidance of triggers that may precipitate metabolic crises (e.g., illness, fasting).
  • Regular monitoring of metabolic status through blood or urine tests.
  • Genetic counseling for families with a history of the disorder.

When to Seek Professional Help

Seek immediate medical attention if symptoms of metabolic crisis occur, such as lethargy, vomiting, seizures, or altered consciousness. Routine follow-up with a metabolic specialist is recommended to manage the condition and prevent complications.

Tips for Medical Coders

Use this code when documentation specifies a disorder of branched-chain amino-acid metabolism without further subclassification. Ensure the diagnosis aligns with clinical findings and laboratory results. If more specific details are available (e.g., isovaleric acidemia, maple syrup urine disease), use the appropriate subclassified code instead. Document the clinical basis for the unspecified diagnosis to support coding accuracy.

Book a walkthrough

E71.2 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.